All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
SANA / Sana Biotechnology, Inc.
|
|
|
|
|
|
|
|
AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
PRAX / Praxis Precision Medicines, Inc.
|
|
|
|
|
|
|
|
TMO / Thermo Fisher Scientific Inc.
|
|
|
|
|
|
|
|
VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
ACHC / Acadia Healthcare Company, Inc.
|
|
|
|
|
|
|
|
ZBH / Zimmer Biomet Holdings, Inc.
|
|
|
|
|
|
|
|
IRTC / iRhythm Technologies, Inc.
|
|
|
|
|
|
|
|
SYK / Stryker Corporation
|
|
|
|
|
|
|
|
EW / Edwards Lifesciences Corporation
|
|
|
|
|
|
|
|
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
HUM / Humana Inc.
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
BDX / Becton, Dickinson and Company
|
|
|
|
|
|
|
|
US516544AB96 / CONV. NOTE
|
|
|
|
|
|
|
|
US09061GAH48 / BioMarin Pharmaceutical, Inc. Bond
|
|
|
|
|
|
|
|
ROIV / Roivant Sciences Ltd.
|
|
|
|
|
|
|
|
KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
THC / Tenet Healthcare Corporation
|
|
|
|
|
|
|
|
ICLR / ICON Public Limited Company
|
|
|
|
|
|
|
|
PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
IQV / IQVIA Holdings Inc.
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GBIO / Generation Bio Co.
|
|
|
|
|
|
|
|
IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
CAH / Cardinal Health, Inc.
|
|
|
|
|
|
|
|
EDIT / Editas Medicine, Inc.
|
|
|
|
|
|
|
|
RCUS / Arcus Biosciences, Inc.
|
|
|
|
|
|
|
|
SGEN / Seagen Inc
|
|
|
|
|
|
|
|
PNT / POINT Biopharma Global Inc.
|
|
|
|
|
|
|
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
NARI / Inari Medical, Inc. Put
|
|
|
|
|
|
|
|
LNTH / Lantheus Holdings, Inc.
|
|
|
|
|
|
|
|
ELV / Elevance Health, Inc.
|
|
|
|
|
|
|
|
DHR / Danaher Corporation
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc. Call
|
|
|
|
|
|
|
|
MCK / McKesson Corporation
|
|
|
|
|
|
|
|
HCA / HCA Healthcare, Inc.
|
|
|
|
|
|
|
|
ALKS / Alkermes plc
|
|
|
|
|
|
|
|
ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
BSX / Boston Scientific Corporation
|
|
|
|
|
|
|
|
CNC / Centene Corporation
|
|
|
|
|
|
|
|
ISRG / Intuitive Surgical, Inc.
|
|
|
|
|
|
|
|
LLY / Eli Lilly and Company
|
|
|
|
|
|
|
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
IOBT / IO Biotech, Inc.
|
|
|
|
|
|
|
|
MOH / Molina Healthcare, Inc.
|
|
|
|
|
|
|
|
UNH / UnitedHealth Group Incorporated
|
|
|
|
|
|
|
|
HOWL / Werewolf Therapeutics, Inc.
|
|
|
|
|
|
|
|
BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
CELC / Celcuity Inc.
|
|
|
|
|
|
|
|
PEN / Penumbra, Inc.
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
DAWN / Day One Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
US64157FAC77 / Nevro Corp
|
|
|
|
|
|
|
|
INBX / Inhibrx Biosciences, Inc.
|
|
|
|
|
|
|
|
US23282WAC47 / CONV. NOTE
|
|
|
|
|
|
|
|
UHS / Universal Health Services, Inc.
|
|
|
|
|
|
|
|
ACLX / Arcellx, Inc.
|
|
|
|
|
|
|
|
SGMT / Sagimet Biosciences Inc.
|
|
|
|
|
|
|
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
TSBX / Turnstone Biologics Corp.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
OSCR / Oscar Health, Inc.
|
|
|
|
|
|
|
|
CRBU / Caribou Biosciences, Inc.
|
|
|
|
|
|
|
|
VEEV / Veeva Systems Inc.
|
|
|
|
|
|
|
|
OM / Outset Medical, Inc.
|
|
|
|
|
|
|
|
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
AVTR / Avantor, Inc.
|
|
|
|
|
|
|
|
ERAS / Erasca, Inc.
|
|
|
|
|
|
|
|
PMVP / PMV Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|